Open Access Open Access  Restricted Access Subscription Access

Laboratory Diagnosis of Cryptococcal Meningitisin Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome Patients at Moi Teaching and Referral Hospital


Affiliations
1 School of Medicine and Health Sciences, Kenya Methodist University, Kenya
 

Cryptococcus meningitis is aserious fungal infectionin HIV patients. India ink is the most used method for rapid detection of Cryptococcus neoformansin CSF specimens. Use of CrAg for laboratory diagnosis of cryptococcus meningitis at M.T.R.H will help reduce mortality. It isimportant therefore to compare the sensitivity of India ink test and CrAgagainst fungal culture for Cryptococcus neoformans in HIV AIDS patients at M.T.R.H. The main objective of the study was to compare the sensitivity of India ink test and CrAg against fungal culture for Cryptococcus neoformans in HIV AIDs patients. The study revealed that CrAg had high sensitivity of 94% and high specificity of 100% compared to 44% sensitivity and 98% specificity of India ink. Level of patients missed for cryptococcus meningitis using India ink was found to be 55.5% compared to 5.6% patients missed by CrAg. Risk ratio of CrAg compared to India ink in this study was 2.12. At 95% confidence interval, the 2.12 estimate is statistically significant at confidence limits of 1.65 and 2.74. In the final analysis, it was found out that cryptococcus meningitis in this study accounted for 18% of defining illnesses in HIV/AIDS patients at M.T.R.H. patients missed for cryptococcosis in the study was higher (55.5%) in India ink compared to that of CrAg. Due to high sensitivity in this study, CrAg test was recommended that it should replace India ink test that was used routinely for diagnosis of cryptococcus meningitis in HIV/AIDS at M.T.R.H.


Keywords

CrAg, India Ink, HIV / AIDs, Risk Ratio, Cryptococcus Meningitis.
User
Notifications
Font Size

  • i. Abadi, J., Nachman, S., Kressel, AB., &Pirofski, L. (1999). Cryptococcosis in children with AIDS.Clin Infect Dis. 28:309313.
  • ii. Aberg, JA.,& Koo JJ. (2000). Increase in the Rate of AIDS-Related Opportunistic Infections at San Francisco General Hospital in the Era of Potent Antiretroviral Therapy.XIII International AIDS Conference, July 9-14, Durban, South Africa.Abstract MoPeB2301.
  • iii. Ann Mwangi., J. Siddle., P. Ayuo., Sidle, J. E., Woods-Kaloustian, K., Kimaiyo, S. N., &Tierney, W. M. (2008). Admission characteristics and outcomes of HIV infected patients registered in an ambulatory HIV care programme in Western Kenya.AIDS Conference, Mexico.
  • iv. A Berlin, L., Pincus, JH. (1989). Cryptococcal meningitis. False negative antigen test results and cultures in non-immuno suppressed patients. Arch Neurol, 46: 1312–1316.
  • v. Cherniak, R., Morris, LC., Belay, T., Spitzer, ED., &Casadevall, A. (1994). Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infection and Immunity. 63:18991905.
  • vi. Chuck, SL., &Sande, MA.(1989). Infections with C. neoformans in acquired immunodeficiency syndrome.N Engl J Med. 321:794-799.
  • vii. Crump, JR., Elner,SG.,Elner, VM., & Kauffman, CA. (1992). Cryptococcalendophthalmitis: Case report and review. Clinical infectious diseases, 14:1069-1073.
  • viii. Cunha, B. A. (2001). Central nervous system infections in the compromised host: a diagnostic approach. Infect. Dis. Clin. N. Am.15:567-590.
  • ix. Currie BP, Casadevall A. (1994). Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis. 19:1029-1033.
  • x. Ellen, Jo, Baron.,&Syndey, M. (1990). Finegold. Diagnostic Microbiology.8th Edition.
  • xi. FA, Odhiambo., EM Murage., W, Ngare., et al. (1997). Detection rates of Cryptococcus neoformans in cerebrospinal fluid specimen at Kenyatta National Hospital, Nairobi. East Afr Med J. Sep; 74 (9): 567-568, 8487434 (P,S,G,E,B).
  • xii. Feldmesser, M., Harris.C., Reichberg, S., Khan, S., &Casadevall, A. (1996).Serum cryptococcal antigen in patients with AIDS. Clinical Infectious Diseases.
  • xiii. Hajjeh, RA., Conn, LA., Stephens,DS., Baughman, W., Hamill, R., Graviss, E., Pappas, PG., Thomas, C., &Reingold, A.(1999). Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virusinfected persons. Cryptococcal Active Surveillance Group. Journal of Infectious Diseases, 179:449-454.
  • xiv. Holtzer, CD., Jacobson,MA., Hadley.WK., Huang, L., Stanley, HD., Montanti, R., Wong, MK., &Stansell, JD.(1998). Decline in the rate of specific opportunistic infections at San Francisco General Hospital, Aids. 12:1931-1933.
  • xv. Joseph, N. Jarvis., Stephen, D. Lawn., Monica, Vogt., Nonzwakazi, Bangani., Robin, Wood.,& Thomas, S. Harrison. (2009). Screening for CryptococcalAntigenaemia in Patients Accessing an Antiretroviral Treatment Program in South Africa. Clin Infect Dis. 1; 48(7): 856–862.
  • xvi. Khanna N, Chandramuki A, Desai A.,& Ravi A. Cryptococcal infection of the central nervous system: an analysis of predisposing factors, laboratoy findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol 1996; 45(5):376-379.
  • xvii. Levitz, SM. (1991). The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13:1163-1169.
  • xviii. Maher, D.,&Mwandumba, H. (1994).Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.J Infect: 28:59–64.
  • xix. Mitchell, TG., &Perfect, JR. (1995). Cryptococcosis in the era of AIDS - 100 years after discovery of Cryptococcus neoformans.ClinMicrobial Rev; 8: 515-548.
  • xx. Manoharan, G., Padmavathy., BK, Vasanthi, S.,&Gopalte, R. (2001).Prvalence of cryptococcus meningitis among HIV/AIDS patients.Indian J. Med Microbiol. 19(3):157-158.
  • xxi. Moosa, MY., &Coovadia, YM. (1997). A comparison of clinical features, laboratory findings and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. Durban, South Africa. Clin Infect Dis J.Feb;24(2):131134.
  • xxii. Murray, PR., Baron EJ., &Pfaller MA.(1999). Tenover FC, Yolken RH.Manual of Clinical Microbiology.7th edition. Washington, DC: ASM Press.
  • xxiii. Park, BJ.,Wannemuehler, KA., Marston, BJ., Govender, N., Pappas, P., & Chiller, T. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living withHIV/AIDS. AIDS Journal. Feb; 23: 525-530.
  • xxiv. P, Mwamba., J, Mwansa., & C, Chintu. (2001). Clinical presentation, natural history and cumulative deaths rates of 230 adults with primary Cryptococcus meningitis in Zambian AIDS patients treated under ;local conditions. Postgrad Med J. 77: 769-773.
  • xxv. Robert, S. Heyderman., Innocent, T. Gangaidzo., James, G. Hakim., Jens, Mielke., Albert, Taziwa., Praise, Musuaire., Valerie J. Robertson.,& Peter, R. Mason. (1998). Cryptococcus meningitis in Human Immunodeficiency Virus – Infected patients in Harare, Zimbabwe. Journal of Clininf dis; 26:284–289.
  • xxvi. Sagg, MS., Powderly WG, Cloud, GA., Robison, P., Grienom, H., Sharrker, PK., & Thompson, SE. (1992). Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis.N Engl J Med. 326:8389.
  • xxvii. Tanner,DC., Weinstein, MP., Fedorciw, B., Joho, KL., Thorpe, JJ.,&Reller, L. (1995).Comparison of commercial kits for detection of cryptococcal antigen. Journalof Clinical Microbiology, 32:1680-1684.
  • xxviii. Tihana, Bicanic. & Thomas, S. Harrison. (2004). Cryptococcus meningitis.British Medical Bulletin. 72: 99-118.
  • xxix. Torres-Guererro, H.,&Edman, JC.(1994). Melanin-deficient mutants of Cryptococcus neoformans Journal of Medicaland Veterinary Mycology, 32:303-313.
  • xxx. Reiss, E., Kaufman, L., Kovacs, JA.,&Lindsley, MD.(2002). Clinical immunomycology. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Laboratory Immunology. 6th ed. Washington, DC: ASM Press; 559-583.
  • xxxi. Woldemanuel, Y. & Haile T. (2001).Cryptococcosis in patients from TikurAnbessa Hospital.Addis Ababa, Ethiopia. Ethiop Med J;39(3):185-192.
  • xxxii. World Health Organization: Laboratory manual for diagnosis offungal opportunistic infections in HIV/AIDS patients. Regional office for South East Asia

Abstract Views: 190

PDF Views: 5




  • Laboratory Diagnosis of Cryptococcal Meningitisin Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome Patients at Moi Teaching and Referral Hospital

Abstract Views: 190  |  PDF Views: 5

Authors

Nancy G. Mbae
School of Medicine and Health Sciences, Kenya Methodist University, Kenya

Abstract


Cryptococcus meningitis is aserious fungal infectionin HIV patients. India ink is the most used method for rapid detection of Cryptococcus neoformansin CSF specimens. Use of CrAg for laboratory diagnosis of cryptococcus meningitis at M.T.R.H will help reduce mortality. It isimportant therefore to compare the sensitivity of India ink test and CrAgagainst fungal culture for Cryptococcus neoformans in HIV AIDS patients at M.T.R.H. The main objective of the study was to compare the sensitivity of India ink test and CrAg against fungal culture for Cryptococcus neoformans in HIV AIDs patients. The study revealed that CrAg had high sensitivity of 94% and high specificity of 100% compared to 44% sensitivity and 98% specificity of India ink. Level of patients missed for cryptococcus meningitis using India ink was found to be 55.5% compared to 5.6% patients missed by CrAg. Risk ratio of CrAg compared to India ink in this study was 2.12. At 95% confidence interval, the 2.12 estimate is statistically significant at confidence limits of 1.65 and 2.74. In the final analysis, it was found out that cryptococcus meningitis in this study accounted for 18% of defining illnesses in HIV/AIDS patients at M.T.R.H. patients missed for cryptococcosis in the study was higher (55.5%) in India ink compared to that of CrAg. Due to high sensitivity in this study, CrAg test was recommended that it should replace India ink test that was used routinely for diagnosis of cryptococcus meningitis in HIV/AIDS at M.T.R.H.


Keywords


CrAg, India Ink, HIV / AIDs, Risk Ratio, Cryptococcus Meningitis.

References